These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8356986)

  • 41. Threat or opportunity? Secondary exchange in a setting with widespread availability of needles.
    Lenton S; Bevan J; Lamond T
    Subst Use Misuse; 2006; 41(6-7):845-64. PubMed ID: 16809175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Commentary on Palmateer et al. (2010): next steps in the global research agenda on syringe access for injection drug users.
    Bluthenthal R; Kral A
    Addiction; 2010 May; 105(5):860-1. PubMed ID: 20402974
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year.
    Hart GJ; Carvell AL; Woodward N; Johnson AM; Williams P; Parry JV
    AIDS; 1989 May; 3(5):261-5. PubMed ID: 2504229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols.
    McCoy CB; Shapshak P; Metsch LR; Rivers JE; McCoy HV; Weatherby NL; Shah SM; Chitwood DD
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):1-9. PubMed ID: 8744677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulating syringe exchange programs: a cautionary note.
    Des Jarlais DC; Paone D; Friedman SR; Peyser N; Newman RG
    JAMA; 1994 Aug; 272(6):431-2. PubMed ID: 8040972
    [No Abstract]   [Full Text] [Related]  

  • 48. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
    Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
    Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Innovative Syringe Exchange Program.
    Potera C
    Am J Nurs; 2017 Jul; 117(7):17. PubMed ID: 28644276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Syringe prescription for injection drug users to prevent disease.
    J Assoc Nurses AIDS Care; 2012; 23(3):275-6. PubMed ID: 22645745
    [No Abstract]   [Full Text] [Related]  

  • 51. The needle-borne HIV epidemic: causes and public health responses.
    Gostin L
    Behav Sci Law; 1991; 9(3):287-304. PubMed ID: 10148824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
    Irwin K; Karchevsky E; Heimer R; Badrieva L
    Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.
    Gostin LO; Lazzarini Z; Jones TS; Flaherty K
    JAMA; 1997 Jan; 277(1):53-62. PubMed ID: 8980211
    [No Abstract]   [Full Text] [Related]  

  • 56. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.
    Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA
    Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.
    Groseclose SL; Weinstein B; Jones TS; Valleroy LA; Fehrs LJ; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):82-9. PubMed ID: 7648290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of new legislation on needle and syringe purchase and possession--Connecticut, 1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Mar; 42(8):145-8. PubMed ID: 8437544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh.
    Pasa MK; Alom KR; Bashri Z; Vermund SH
    PLoS One; 2016; 11(2):e0148276. PubMed ID: 26848756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.